Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04427293
Title Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC)
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Illinois at Chicago
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.